Matt Zuga

Director, TELA Bio, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 22, 2026Sold 1,687 shares at $1.86 of Acumen Pharmaceuticals, Inc.⁵
Jan 21, 2026Sold 2,473 shares at $1.81 of Acumen Pharmaceuticals, Inc.⁵
Jan 16, 2026Granted 99,133 shares of Acumen Pharmaceuticals, Inc.⁶
Jan 8, 2026Sold 6,888 shares at $1.82 of Acumen Pharmaceuticals, Inc.⁷
Jan 7, 2026Sold 1,700 shares at $1.99 of Acumen Pharmaceuticals, Inc.⁸
Jan 7, 2026Sold 4,105 shares at $2.00 of Acumen Pharmaceuticals, Inc.⁸
Jan 6, 2026Sold 5,100 shares at $1.97 of Acumen Pharmaceuticals, Inc.⁸
Jan 5, 2026Sold 4,000 shares at $1.96 of Acumen Pharmaceuticals, Inc.⁸
Jan 23, 2025Sold 28,902 shares at $1.72 of Acumen Pharmaceuticals, Inc.⁹
Jan 21, 2025Sold 4,364 shares at $1.60 of Acumen Pharmaceuticals, Inc.⁹
Jan 6, 2025Granted 66,800 shares of Acumen Pharmaceuticals, Inc.¹⁰
Jan 3, 2025Sold 13,235 shares at $1.84 of Acumen Pharmaceuticals, Inc.¹⁰
Jan 18, 2024Sold 4,242 shares at $3.71 of Acumen Pharmaceuticals, Inc.¹¹
Jan 2, 2024Granted 106,000 shares of Acumen Pharmaceuticals, Inc.¹²
Jan 17, 2023Granted 33,500 shares of Acumen Pharmaceuticals, Inc.¹³
Dec 29, 2022Exercised options 50,000 shares at $1.19 of Acumen Pharmaceuticals, Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.